glp-1 and kidney disease Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus chronic disease: an approach for the nephrologist Glucagon-like Peptide Receptor Agonists and

This comprehensive review synthesizes current evidence on the mechanisms, established ...

GLP-1 patches for weight loss have made the scenebut a leading MD warns you they aren't the same as the more familiar prescriptions.

Discover what current FDA data and clinical trials reveal about GLP-1 medications like Ozempic, Wegovy, and Mounjaro and cancer safety concerns.

Together, these episodes explore how GLP-1 medications work, who theyre designed for, their potential benefits and risks, what were seeing both in practice and in the broader population, what the science says, and what active people need to know

See if you qualify now!

In this article, we break down what to do before stopping a GLP-1, including addressing gut health, insulin resistance, hormone balance, mitochondrial function, inflammation, nutrient deficiencies, muscle mass, and the true drivers of cravings.